An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II
NCT05754450
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
2
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukocyte Adhesion Deficiency
Interventions
DRUG:
AVTX-803
Sponsor
AUG Therapeutics